The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumours|Breast Cancer|Ovarian Cancer|Prostate Cancer|Primary Peritoneal Cancer
Interventions: DRUG: IMP4297
Sponsor: Impact Therapeutics, Inc.